Profund Advisors LLC Abb Vie Inc. Transaction History

Profund Advisors LLC

$2.65 Billion
Q2 2024

A detailed history of Profund Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 47,004 shares of ABBV stock, worth $9.42 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

47,004

Previous 35,401 32.78%

Holding current value

$9.42 Million

Previous $6.45 Million 25.07%

% of portfolio

0.3%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $1.8 Million - $2.1 Million	11,603 Added 32.78%	47,004 $8.06 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $487,770 - $555,769	-3,052 Reduced 7.94%	35,401 $6.45 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $179,430 - $202,080	1,304 Added 3.51%	38,453 $5.96 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $218,954 - $253,471	-1,639 Reduced 4.23%	37,149 $5.54 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $400,312 - $498,162	3,021 Added 8.45%	38,788 $5.23 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $24.8 Million - $28.6 Million	-171,534 Reduced 82.75%	35,767 $5.7 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $580,487 - $696,156	4,197 Added 2.07%	207,301 $33.5 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $1.18 Million - $1.35 Million	-8,788 Reduced 4.15%	203,104 $27.3 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $3.05 Million - $3.88 Million	-22,171 Reduced 9.47%	211,892 $32.5 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $3.14 Million - $3.9 Million	-23,828 Reduced 9.24%	234,063 $37.9 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $4.57 Million - $5.78 Million	-42,503 Reduced 14.15%	257,891 $34.9 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.56 Million - $1.77 Million	-14,680 Reduced 4.66%	300,394 $32.4 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $917,641 - $1.02 Million	-8,722 Reduced 2.69%	315,074 $35.5 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $5.3 Million - $5.83 Million	-51,810 Reduced 13.79%	323,796 $35 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $2.57 Million - $3.47 Million	31,902 Added 9.28%	375,606 $40.2 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $5.45 Million - $6.4 Million	-63,425 Reduced 15.58%	343,704 $30.1 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $8.5 Million - $11.4 Million	115,822 Added 39.76%	407,129 $40 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $6.85 Million - $10.4 Million	-106,197 Reduced 26.72%	291,307 $22.2 Million
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $2.92 Million - $3.65 Million	40,453 Added 11.33%	397,504 $35.2 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.65 Million - $1.99 Million	-26,220 Reduced 6.84%	357,051 $27 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $2.85 Million - $3.64 Million	-43,333 Reduced 10.16%	383,271 $27.9 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $36,255 - $42,671	-470 Reduced 0.11%	426,604 $34.4 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $8.89 Million - $11 Million	-114,171 Reduced 21.09%	427,074 $39.4 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $4.31 Million - $4.79 Million	48,424 Added 9.83%	541,245 $51.2 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $5.51 Million - $6.52 Million	-61,365 Reduced 11.07%	492,821 $45.7 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $5.01 Million - $6.71 Million	-54,429 Reduced 8.94%	554,186 $52.5 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $6.59 Million - $7.23 Million	-73,623 Reduced 10.79%	608,615 $58.9 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $3.66 Million - $4.67 Million	52,391 Added 8.32%	682,238 $60.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	629,847	629,847 $45.7 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Abb Vie Inc. Transaction History